Important Safety Information

BRAVECTO (fluralaner topical solution) for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats has not been shown to be effective for 12-weeks’ duration in kittens less than 6 months of age.  BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing.  For topical use only. Avoid oral ingestion.   

The safety of BRAVECTO Topical Solution for Cats has not been established in breeding, pregnant and lactating cats.  Fluralaner is a member of the isoxazoline class.  This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.